Consensus EPS · Q2 2026
$0.98
Consensus revenue · Q2 2026
$1.5B
Analysts
11
Expected report
Jul 23, 2026
Analyst consensus (locked)
Analyst consensus
Based on estimates from 11 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.5B |
| EPS | $0.96 | $0.98 | $1.01 |
| EBITDA | $470.8M | $484.3M | $497.8M |
| EBIT | $385.6M | $396.6M | $407.6M |
| Net income | $549.5M | $560.9M | $572.4M |
- Revenue$1.5B
- EPS$0.98
- EBITDA$484.3M
- EBIT$396.6M
- Net income$560.9M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.4B | $1.4B | +2.6% | $0.96 | $0.93 | +3.2% |
| Q4 2025 | $1.4B | $1.4B | +1.7% | $0.96 | $0.92 | +4.2% |
- Q1 2026+2.6%+3.2%
- Q4 2025+1.7%+4.2%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Nasdaq (NDAQ) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 2 analysts.
- Low
- $110.00
- Consensus
- $112.00
- Median
- $112.50
- High
- $113.00
- Current
- $90.90
- Upside
- +23.2%
Upside calculated vs most recent trading price of $90.90.
Analyst ratings
Consensus: Buy — based on 36 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 10, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Jul 9, 2026 | Raymond James | maintain | Outperform | Outperform |
| Jul 9, 2026 | Barclays | maintain | Overweight | Overweight |
| Jun 22, 2026 | TD Cowen | maintain | Buy | Buy |
| Apr 24, 2026 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Apr 13, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 8, 2026 | Barclays | maintain | Overweight | Overweight |
| Feb 26, 2026 | TD Cowen | upgrade | Hold | Buy |
| Jan 30, 2026 | TD Cowen | maintain | Hold | Hold |
- Jul 20, 2026TD CowenBuy
- Jul 10, 2026Morgan StanleyOverweight
- Jul 9, 2026Raymond JamesOutperform
- Jul 9, 2026BarclaysOverweight
- Jun 22, 2026TD CowenBuy
- Apr 24, 2026Keefe, Bruyette & WoodsMarket Perform
- Apr 13, 2026BarclaysOverweight
- Apr 8, 2026BarclaysOverweight
- Feb 26, 2026TD CowenBuy
- Jan 30, 2026TD CowenHold
Frequently asked questions
Nasdaq (NDAQ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.18% TTM
- Dividend Profile1.23% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.